ACCESS TO VORASIDENIB IN THE UK
When news first broke of the successful trials of Vorasidenib on Low Grade Glioma (LGG) brain tumour patients, many patients and their families were of the opinion that, at last, there was hope for the future. But it would appear that, at present, this hope is unfounded for patients here in the UK. So we are asking you to please sign this petition to put pressure on the suppliers, Servier to make this drug available in the UK>
LGGs afflict mainly young people – some have not finished their education, many have just begun their careers, some are hoping to start a family whilst some already have children. All are desperate for an effective treatment to enable them to live their lives as fully as possible.
Please click on the link to sign the petition.